BSX · ISSUER CIK 885725
BOSTON SCIENTIFIC CORP
Between Aug 1, 2026 and Oct 29, 2026, 8 BOSTON SCIENTIFIC CORP insiders reported $9.5M of open-market purchases and $0.00 of sales on SEC Form 4. The largest buyer was Mahoney Michael F (Chairman, President & CEO, Director), with $9.0M.
↗8 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$9.5MInsider buying
$0.00Insider selling
+$9.5MNet open-market
Sep 3, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 3, 202616:34 | Sep 2, 2026 | BSX | EVP, Global Operations | M · Exercise | — | +1,171 | 8,459 | +16% | — | ||
| Sep 3, 202616:34 | Sep 2, 2026 | BSX | EVP, Global Operations | F · Tax | $48.37 | −567 | 7,892 | -7% | $27K | ||
| Aug 26, 202618:46 | Aug 25, 2026 | BSX | Director | P · Buy | $49.22 | +2,040 | 13,784 | +17% | +$100K | -5.4% | -13.3% |
| Aug 12, 202616:08 | Aug 11, 2026 | BSX | SVP, Global Controller and CAO | I · Plan | $51.19 | +2,930 | 2,930 | New | $150K | ||
| Aug 11, 202616:39 | Aug 10, 2026 | BSX | EVP and CFO | I · Plan | $50.46 | +9,908 | 9,908 | New | $500K | ||
| Aug 7, 202616:16 | Aug 5, 2026 | BSX | Director | P · Buy | $47.59 | +2,100 | 17,160 | +14% | +$100K | -17.6% | -10.3% |
| Aug 5, 202616:15 | Aug 4, 2026from Aug 3, 2026 | BSX | Director | P · Buy | $48.13 | +1,182 | 15,060 | +9% | +$57K | -16.7% | -11.3% |
| Aug 5, 202616:15 | Aug 3, 2026 | BSX | Chairman, President & CEO, Director | P · Buy | $48.33 | +186,240 | 1,590,024 | +13% | +$9.0M | -16.4% | -11.7% |
| Aug 5, 202616:15 | Aug 3, 2026 | BSX | Chairman, President & CEO, Director | I · Plan | $48.43 | +22,119 | 22,119 | New | $1.1M | ||
| Aug 3, 202616:29 | Jul 31, 2026 | BSX | Director | P · Buy | $45.48 | +5,000 | 30,359 | +20% | +$227K | -21.3% | -6.1% |
| Aug 3, 202616:29 | Jul 31, 2026 | BSX | EVP & Group Pres, Cardiology | I · Plan | $46.73 | +64,198 | 64,198 | New | $3.0M |